The Hypothalamic-Pituitary Axis in PCOS-Reference-Cited by-同舟云学术

The Hypothalamic-Pituitary Axis in PCOS

Published:2022 Issue: Volume: Page:73-93
ISSN:
Container-title:Polycystic Ovary Syndrome
language:
Short-container-title:

Author:

Okigbo Chinelo C.,Gill Sabrina,Hall Janet E.

Publisher

Springer International Publishing

Link

https://link.springer.com/content/pdf/10.1007/978-3-030-92589-5_5

Reference97 articles.

1. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41–7.

2. Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev. 2016;37(5):467–520.

3. Hall J. Disorders of the female reproductive system. In: Jameson JL Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J. Harrison’s principles of internal medicine 20th: McGraw-Hill; 2018. p. 385–388. New York

4. Hall J. Neuroendocrine control of the menstrual cycle. In: Strauss JF, Barbieri RL, editors. Yen and Jaffe’s reproductive endocrinology. 8th ed. Philadelphia: Elsevier; 2019. p. 149–66. e5.

5. Filicori M, Butler JP, Crowley WF. Neuroendocrine regulation of the corpus luteum in the human. Evidence for pulsatile progesterone secretion. J Clin Invest. 1984;73(6):1638–47.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ameliorative Effect of Chitosan-Propolis Nanoparticles on the Estradiol Valerate-Induced Polycystic Ovary Syndrome Model;Jundishapur Journal of Natural Pharmaceutical Products;2023-11-02